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Abstract
Background: Characterizing and comparing the determinant of cotinine concentrations in different populations
should facilitate a better understanding of smoking patterns and addiction. This study describes and characterizes
determinants of salivary cotinine concentration in a sample of Spanish adult daily smoker men and women.
Methods: A cross-sectional study was carried out between March 2004 and December 2005 in a representative
sample of 1245 people from the general population of Barcelona, Spain. A standard questionnaire was used to
gather information on active tobacco smoking and passive exposure, and a saliva specimen was obtained to
determine salivary cotinine concentration. Two hundred and eleven adult smokers (>16 years old) with complete
data were included in the analysis. Determinants of cotinine concentrations were assessed using linear regression
models.
Results: Salivary cotinine concentration was associated with the reported number of cigarettes smoked in the
previous 24 hours (R2 = 0.339; p < 0.05). The inclusion of a quadratic component for number of cigarettes smoked
in the regression analyses resulted in an improvement of the fit (R2 = 0.386; p < 0.05). Cotinine concentration
differed significantly by sex, with men having higher levels.
Conclusion: This study shows that salivary cotinine concentration is significantly associated with the number of
cigarettes smoked and sex, but not with other smoking-related variables.
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Background
Nicotine, the main alkaloid of tobacco, is responsible for
its addictive effect. It is readily absorbed from tobacco
smoke, and its concentration rises over 6-8 hours during
the day in regular smokers [1]. About 70 to 80% of nico-
tine is metabolized to cotinine [2]. As the primary metab-
olite of nicotine, cotinine has been widely used as a
specific biomarker of tobacco exposure because its half-
life in the body (12-20 hours) is longer than that of nico-
tine (3-4 hours) [1,2]. Cotinine in biological materials is
suitable for assessment of doses over short periods of time
(from 1 to 10 days, in urine, plasma, or saliva) or longer
periods (weeks or months, in hair or nails). Consequently
cotinine concentration is feasibly used as a biomarker in
epidemiological studies [3-5].
Cotinine measurements have been used to describe and
compare patterns of tobacco consumption in smokers in
different countries to establish if addiction and smoking
patterns vary across populations [6-8]. These studies show
that the number of cigarettes smoked is the main determi-
nant of salivary cotinine concentrations [9]. These studies
have been conducted in selected samples from a variety of
countries at different stages of the tobacco epidemic, such
as China, Mexico, Brazil, and Poland [9,10]. However,
there is scant information about the relation between coti-
nine measurements and smoking patterns in samples
from the general population.
Spain is currently in an advanced stage of the tobacco epi-
demic [10,11]. Data from the 2006 Spanish National
Health Interview Survey show prevalence rates of daily
smokers of 31.6% and 21.5% in adult men and women,
respectively [12]. In men, a steady increase in smoking
occurred during the first half of the twentieth century,
reaching a peak prevalence rate of 59.1% in the nineteen-
seventies. This peak was followed by a decade of stabiliza-
tion and a continued decrease of smoking until the
present. Uptake of smoking in women was delayed, with
a prevalence rate of 5% through the nineteen-seventies.
This was followed by a substantial increase throughout
the next two decades (22.5% by 1995), which only
recently stopped [11,13,14].
An understanding of cotinine concentration and smoking
patterns at the population level is potentially useful to
design suitable strategies for cessation. The aim of this
study is to describe and characterize the distribution of
salivary cotinine concentration in a representative sample
of adult (>16 years old) daily smokers in Barcelona,
Spain.
Methods
Study design and subjects
We conducted a cross-sectional study among the general
population of Barcelona, Spain, between March 2004 and
December 2005. A representative random sample by age,
sex, and district was drawn from the official 2001 popula-
tion census of Barcelona, a reliable source of population-
based information. To detect a difference in cotinine con-
centration in smokers of 50 ng/ml (with a mean value of
500 ng/ml and a standard deviation of 200 ng/ml), with
an alpha of 5% and a beta of 10% (statistical power of
90%), we estimated that a sample size of 337 smokers
would be needed. Considering a 27% prevalence of smok-
ing from the 2001 Health Survey of Barcelona, we esti-
mated a needed sample size of 1560 people, taking into
account smokers and non-smokers. In cases of non-
response, substitution by persons of the same sex within
the 5-year age group and residing in the same district was
allowed according to protocol.
Smoking status, secondhand smoke exposure as well as
demographic information were obtained by question-
naire, and a saliva specimen was collected to determine
cotinine concentration. The research and ethics commit-
tee of the Bellvitge University Hospital approved the study
protocol, and informed consent was obtained from all
participants. The procedure was as follows: a personal let-
ter was sent to eligible participants, and trained interview-
ers contacted the subjects (or a proxy for children) at
home and informed them about the study. Participants
signed the consent form, answered a questionnaire, and
provided a saliva specimen at home. The study ended in
December 2005 with a new Spanish law banning smoking
in public places and enclosed workplaces coming into
effect in January 2006 [15]. We expected changes in smok-
ing behavior after this date (number of cigarettes smoked
by smokers and passive exposure levels in nonsmokers)
and hence 315 selected participants were not approached.
By the end of the study, 1245 subjects had been inter-
viewed (participation rate of 79.8% from the initial sam-
ple drawn). The study design allowed replacement of the
index person by another person of the same sex, 5-year
age group, and district of residence. In 49.3% of cases the
first selected index person was interviewed; 24.4% of first
substitutes were interviewed; and 26.3% of second or sub-
sequent substitutes were interviewed. The final sample
interviewed included 285 daily smokers (at least 1 ciga-
rette per day), 62 occasional (non-daily) smokers, 354 ex-
smokers, 525 never-smokers, and 19 people were less
than 17 years of age. The present report is based on adults
who were daily smokers.
Measures
Questionnaire
We obtained information on demographics, and levels of
secondhand smoke exposure at home, work or study cen-
tre, and during leisure time. Detailed information was
also collected on self-reported smoking for smokers:
number of cigarettes smoked daily, number of cigarettes
smoked during the previous 24 and 48 hours, duration ofBMC Public Health 2009, 9:320 http://www.biomedcentral.com/1471-2458/9/320
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smoking, brand of cigarettes smoked most often, brands
of cigarettes smoked during the survey day and in the pre-
vious day, use of cigarettes with filter tips, depth and fre-
quency of inhalation, use of other tobacco products, and
use of nicotine gum or patches.
Body mass index
We measured participants' weights and heights using a
standardized protocol (with an electronic portable scale
and a tape measure). Body mass index (BMI) was com-
puted as weight/squared height (kg/m2) and stratified
using standard categories of BMI (underweight: <18.50,
normal: 18.50-24.99, overweight: 25.00-29.99, and
obese: ≥30.00 kg/m2).
Saliva specimen
A standardized protocol for saliva collection was used.
Participants were asked to rinse their mouths and then
suck a lemon-flavored candy (Smint®) to stimulate saliva
production. They were asked first to spit out a small
amount of saliva, and then to spit about 8 ml into a poly-
propylene test tube. The specimens were kept at 4°C and
then frozen at -20°C in 3 ml aliquots for transport in dry
ice to the Bioanalysis Research Group of the Municipal
Institute for Medical Research (IMIM-Hospital del Mar).
Cotinine concentration in nanograms per milliliter (ng/
ml) was determined by gas chromatography, with detec-
tion by mass spectrometry (GC/MS) [16,17]. With this
technique, cotinine concentration can be quantified as
low as 1 ng/ml (limit of detection: 0.3 ng/ml; quantifica-
tion error <15%).
Data analyses
Sample exclusions
Of the 285 current adult daily smokers, 7 were excluded
from the analysis either because they did not provide a
saliva specimen or that cotinine determination was not
possible (i.e., insufficient sample). We included only cig-
arette smokers, hence 53 people who smoked other
tobacco products (mainly cigars and roll tobacco) were
excluded, as were 2 subjects who used nicotine gum or
nicotine patch for cessation. Additionally, 12 people were
excluded because their cotinine concentrations were too
high in relation to the self-reported consumption, that is,
over 35 ng/ml per one cigarette smoked. This level of coti-
nine represents the maximum level of absorption per one
cigarette smoked, assuming that the typical cotinine con-
centration of 12 ng/ml per cigarette is equivalent to the
usual absorption of 1 mg of nicotine per cigarette, and
that a cigarette smoker can absorb up to 3 mg of nicotine
per cigarette with very intense smoking [9]. The final sam-
ple for analysis consisted of 211 current daily smokers.
Variables
The outcome variable was salivary cotinine concentration
(ng/ml). Potential modifiers of the relation between coti-
nine concentration and the number of cigarettes smoked
in the last 24 hours included individual characteristics
(sex, age, educational level, BMI), type of tobacco (use of
regular or non-regular cigarettes [light, ultralight, mentho-
lated, low nicotine yield], use of blond or black tobacco,
and use of filter tips), and smoking behavior (frequency
and depth of smoke inhalation).
Statistical analyses
Medians and 25th and 75th percentiles (interquartile
range, IQR) of salivary cotinine concentration were com-
puted according to the different strata of the potential
modifiers. Median cotinine concentrations across the dif-
ferent variables were compared using non-parametric test
for medians. Simple linear regression was used to derive
the average increase in cotinine level (ng/ml) per one cig-
arette smoked, adjusting for the remaining variables. We
analyzed the relation between number of cigarettes
smoked in the previous 24 hours and salivary cotinine
concentration using multiple linear regressions according
to the strata of the potential modifiers of interest. Since
the distributions of cotinine concentration and of the
number of cigarettes were skewed, we first used log trans-
formation, but the fit of the models did not improve. Fol-
lowing previous studies [9,18], we included a quadratic
term for number of cigarettes to improve the models' fit.
We assessed the improvement of fit between the adjusted
and simple model with the F test statistic [19]. All models
were tested for the applicability of conditions of linear
regression (model specification, normality of errors,
homoscedasticity, absence of multicollinearity, absence
of outliers and lack of self-correlation). All analyses were
performed using SPSS v13.0 (SPSS Inc., Chicago, IL).
Results
Among the 211 current daily smokers (104 men and 107
women), the median age was 42.0 years (IQR 31.0-53.0).
The sample was uniformly distributed across educational
levels. The majority of participants (56%) were of normal
weight and 19.4% had smoked more than 20 cigarettes in
the last 24 hours. The median number of cigarettes
smoked according to selected sociodemographic and
smoking characteristics is shown in Table 1. The median
number of cigarettes smoked in the last 24 hours was 15.0
(IQR 8.0-20.0), with significantly higher consumption in
men compared to women (p < 0.05). Differences in ciga-
rette consumption were also found by type of tobacco:
smokers of black tobacco had smoked more cigarettes in
the last 24 hours (median: 20 cigarettes) than smokers of
blond tobacco (median: 12 cigarettes, p < 0.05).
Median cotinine concentrations by individual characteris-
tics and smoking parameters are shown in Table 2. The
overall median cotinine concentration was 146.5 ng/ml
(IQR 86.8-220.5). Median cotinine concentration differed
significantly by sex (172.6 ng/ml for men and 120.7 ng/BMC Public Health 2009, 9:320 http://www.biomedcentral.com/1471-2458/9/320
Page 4 of 11
(page number not for citation purposes)
ml for women, p < 0.001) regardless of the number of cig-
arettes smoked. Significant differences in cotinine concen-
trations were not found by age, educational level, or BMI
(Table 2).
As shown in Table 2, we found no statistically significant
differences in the salivary cotinine concentration by type
of cigarettes, use of filter, frequency, or depth of inhala-
tion. Median cotinine concentration was higher among
smokers of black tobacco (180.2 ng/ml) than among
smokers of blond tobacco (137.0 ng/ml; p = 0.043). This
association was confounded by the higher median con-
sumption by smokers of black tobacco (Table 1), and by
the predominance of men (70%) among users of black
tobacco. There was no association between the type of
tobacco smoked and cotinine concentration within strata
of number of cigarettes smoked (1-9, 10-19, and = 20 cig-
arettes in the last 24 hours) or of sex (data not shown).
Coefficients (β) derived from simple linear regression esti-
mate the average increase in cotinine concentration per
one cigarette smoked during the previous 24 hours (Table
3). The increase in cotinine concentration per one ciga-
rette smoked was 5.3 ng/ml in men and 7.7 ng/ml in
Table 1: Median number of cigarettes smoked in the last 24 hours and interquartile ranges in adult daily smokers, according to 
individual characteristics, type of tobacco, and smoking characteristics. 
nm e d i a n   (IQR*) p-value†
Total 211 15.0 (8.0, 20.0) -
Individual characteristics
Sex 0.002
Men 104 20.0 (10.0, 25.0)
women 107 10.0 (6.0, 20.0)
Age (years) 0.073
17-44 120 12.5 (8.3, 20.0)
45-64 79 19.0 (10.0, 25.0)
≥ 65 12 8.5 (4.8, 18.0)
Educational level 0.162
Less than primary and primary 68 16.5 (10.0, 20.0)
secondary 74 14.5 (8.8, 20.0)
university 68 11.5 (6.0, 20.0)
Body mass index (kg/m2)‡ 0.705
underweight 4 10.0 (7.0, 17.5)
normal 116 14.0 (8.0, 20.0)
overweight 66 15.0 (8.0, 20.8)
obese 21 20.0 (8.5, 30.0)
Type of tobacco
Type of cigarettes 0.040
regular 148 15.0 (8.5, 20.0)
non-regular (light, ultralight, etc.) 63 10.0 (8.0, 20.0)
Type of tobacco 0.003
blond 171 12.0 (8.0, 20.0)
black 40 20.0 (10.5, 28.8)
Use of filter tip 0.207
with filter 209 15.0 (8.0, 20.0)
without filter 2 7.0 (4.0, 10.0)
Smoking characteristics
Frequency of inhalation 0.014
all the time 21 20.0 (10.5, 20.0)
half the time 150 11.0 (7.0, 20.0)
seldom 39 20.0 (12.0, 30.0)
Depth of inhalation 0.739
light 22 16.0 (10.0, 22.5)
moderate 78 12.0 (7.9, 20.0)
deep 108 15.0 (8.0, 20.0)
Barcelona (Spain), 2004-2005.
* IQR: interquartile range
† non-parametric test for medians
‡ underweight: <18.50 kg/m2; normal: 18.50-24.99 kg/m2; overweight: 25.00-29.99 kg/m2; obese: _30.00 kg/m2BMC Public Health 2009, 9:320 http://www.biomedcentral.com/1471-2458/9/320
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women. No consistent trend was found in cotinine con-
centration by age; the greatest increase was observed in
participants <45 years (β = 7.0; 95% CI, 5.2 - 8.8 ng/ml).
Cotinine level increase per one cigarette smoked was
greater among subjects who were at normal weight (8.2
ng/ml) and overweight (6.5 ng/ml) than in those who
were obese (1.9 ng/ml). By type of tobacco, the greatest
increase in cotinine concentration per one cigarette
smoked was found in those smoking non-regular ciga-
rettes (8.4 ng/ml) and in smokers of blond tobacco (6.9
ng/ml). Consistent trends were not found by use of filter
tip, frequency, or depth of inhalation.
The distribution of salivary cotinine concentration in rela-
tion to the number of cigarettes smoked during the 24
hours prior to saliva collection is shown in Fig 1. In the
simple unadjusted linear model the number of cigarettes
smoked in the last 24 hours was a predictor of cotinine
concentrations (R2  = 0.339; solid line). A significant
improvement of the fit was obtained with a quadratic
model, in which the number of cigarettes smoked
accounted for almost 39% (adjusted R2) of the variance,
and the exposure-response relationship leveled-off near
20 cigarettes (Fig. 1; dashed line). [see Additional file 1]
Table 2: Median cotinine concentrations (ng/ml) and interquartile ranges in adult daily smokers, according to individual 
characteristics, type of tobacco, and smoking characteristics. 
n median (IQR*) p-value†
Total 211 146.5 (86.8, 220.5) -
Individual characteristics
Sex
men 104 172.6 (115.3, 255.4) < 0.001
women 107 120.7 (69.6, 208.8)
Age (years)
17-44 120 127.1 (82.8, 297.1) 0.090
45-64 79 171.1 (103.9, 239.4)
≥ 65 12 135.8 (54.6, 215.7)
Educational level
less than primary and primary 68 173.9 (106.1, 295.8) 0.194
secondary 74 134.4 (86.5, 216.2)
university 68 137.7 (67.4, 194.7)
Body mass index (kg/m2)‡
underweight 4 132.3 (72.4, 281.8) 0.151
normal 116 127.9 (85.1, 219.5)
overweight 66 155.3 (88.7, 223.3)
obese 21 166.6 (91.2, 224.2)
Type of tobacco
Type of cigarettes
regular 148 149.5 (96.6, 229.8) 0.313
non-regular (light, ultralight, etc.) 63 128.4 (74.7, 214.8)
Type of tobacco
blond 171 137.0 (84.5, 219.6) 0.043
black 40 180.2 (128.6, 259.5)
Use of filter tip
with filter 209 146.9 (89.7, 220.5) 0.157
without filter 2 41.9 (12.7, 71.0)
Smoking characteristics
Frequency of inhalation
all the time 21 166.6 (101.5, 207.1) 0.473
half the time 150 137.1 (83.1, 220.2)
seldom 39 177.3 (108.6, 248.8)
Depth of inhalation
light 22 151.3 (80.6, 306.9) 0.957
moderate 78 142.8 (98.8, 220.2)
deep 108 146.7 (84.8, 213.7)
Barcelona (Spain), 2004-2005.
* IQR: interquartile range
† non-parametric test for medians
‡ underweight: <18.50 kg/m2; normal: 18.50-24.99 kg/m2; overweight: 25.00-29.99 kg/m2; obese: _30.00 kg/m2BMC Public Health 2009, 9:320 http://www.biomedcentral.com/1471-2458/9/320
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Due to differences found in cotinine concentrations
between men and women, we analyzed these groups sep-
arately (Table 4). We observed an increment of 15.7 and
11.2 ng/ml in cotinine concentration per one cigarette
smoked at a consumption of 1 cigarette per day in the
quadratic model for men and for women, respectively.
Further adjustment for age, educational level, and BMI in
the quadratic model showed the best fit of the data with a
similar increase in the cotinine concentration by cigarettes
smoked (Table 4). Adjustment for other potential con-
founders identified in the bivariate analysis did not
improve the model fit and hence these variables were not
included in the final models (data not shown). Fig 2
shows the regression lines from linear and quadratic mod-
els for men and women. We verified the final models for
error specification, normality, homoscedasticity, multi-
collinearity, outliers and self-correlation, and all diagnos-
tics showed that the chosen models fulfilled the
assumption [see Additional file 1]
Discussion
This is the first study on smoking behavior in a Spanish
adult population using both a questionnaire and a
biomarker of tobacco exposure. Salivary cotinine concen-
Table 3: Average increase in cotinine concentration (ng/ml) in adult daily smokers per one cigarette smoked in the previous 24 hours, 
according to individual characteristics, type of tobacco, and smoking characteristics. Barcelona (Spain), 2004-2005.
n β *9 5 %  C I † R2
Total 211 6.4 5.2, 7.7 0.338
Individual characteristics
Sex
men 104 5.3 3.5, 7.2 0.244
women 107 7.7 5.9, 9.5 0.412
Age (years)
17-44 120 7.0 5.2, 8.8 0.329
45-64 79 5.8 3.9, 7.8 0.329
≥ 65 12 6.1 -0.2, 12.5 0.316
Educational level
less than primary and primary 68 5.4 2.9, 7.8 0.226
secondary 74 6.5 4.6, 8.4 0.392
university 68 7.5 5.4, 9.6 0.435
Body mass index (kg/m2)‡
underweight 4 --§ --§ --§
normal 116 8.2 6.5, 9.9 0.439
overweight 66 6.5 4.3, 8.7 0.350
obese 21 1.9 -0.8, 4.8 0.102
Type of tobacco
Type of cigarettes
regular 148 5.8 4.4, 7.2 0.321
non-regular (light, ultralight, etc.) 63 8.4 5.7, 11.1 0.395
Type of tobacco
blond 171 6.9 5.5, 8.3 0.356
black 40 5.1 2.1, 8.0 0.244
Use of filter tip
with filter 209 6.3 5.1, 7.6 0.333
without filter 2 --§ --§ --§
Smoking characteristics
Frequency of inhalation
all the time 21 5.9 2.3, 9.5 0.384
half the time 150 8.4 6.8, 9.9 0.439
seldom 39 3.3 0.6, 6.0 0.147
Depth of inhalation
light 22 7.9 2.8, 13.0 0.348
moderate 78 4.9 2.7, 7.0 0.217
deep 108 6.8 5.2, 8.3 0.416
Barcelona (Spain), 2004-2005.
* estimates from simple linear regression
† 95% confidence interval of _
‡ underweight: <18.50 kg/m2; normal: 18.50-24.99 kg/m2; overweight: 25.00-29.99
kg/m2; obese: _30.00 kg/m2
§not computed for insufficient observationsBMC Public Health 2009, 9:320 http://www.biomedcentral.com/1471-2458/9/320
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tration was associated with the number of cigarettes
smoked in the last 24 hours. This relation was better
explained with a quadratic function and in separate strata
for men and women. The greater the number of cigarettes
smoked, the greater the cotinine concentration in a linear
scale up to 20 cigarettes per day, after which the associa-
tion plateaus. A similar relation between salivary [6-9,20]
or serum [21] cotinine concentrations and number of cig-
arettes smoked has been observed in other studies.
Abrams et al. dichotomized tobacco consumption, and
found that for smokers of less than 25 cigarettes per day,
salivary cotinine concentration was highly correlated with
tobacco consumption, while among heavier smokers the
relation was not evident [22].
Other studies have found that cotinine concentration pla-
teaus at different numbers of cigarettes: 25 cigarettes per
day [23], 5 cigarettes per day [24], and 4 cigarettes per day
in adolescent smokers [25]. The evidence suggests that
cotinine concentration rises in a non-linear fashion with
increasing number of cigarettes smoked, but the point
where concentrations level off may vary across different
populations. This finding suggests a difference in how
people regulate their intake of nicotine to reach the
desired dose [2], even for adolescents, who may be more
susceptible to nicotine than adults and require only 4-5
cigarettes per day to satisfy their nicotine cravings [25].
We observed that cotinine concentrations differed by sex,
regardless of the number of cigarettes smoked. Some stud-
ies reported similar findings of higher cotinine concentra-
tions in men than in women [7,23,26,27], but other
studies did not find differences by sex [6,28]. Association
between urinary cotinine and cigarettes smoked according
to sex was found in a study in the USA: urinary cotinine
concentrations in men increased up to 34 cigarettes per
day and then declined, while no flattening was observed
in women [29]. The differences we observed by sex could
reflect not only differences in tobacco consumption by
sex, i.e., men usually smoke more cigarettes than women,
but also a difference in the metabolism of nicotine
between men and women [30,31].
Our data showed a higher cotinine concentration in
smokers of black tobacco that did not persist with control
for the number of cigarettes smoked. Whereas uptake of
carcinogens is higher among black tobacco smokers [32-
34], differences in nicotine uptake by type of tobacco
smoked have not been reported [35]. In our study, use of
filter, frequency, and depth of inhalation were not related
to cotinine concentrations. An explanation of these results
could be that smokers tend to maintain the same intake
level of nicotine by drawing in more smoke per cigarette
when they try to smoke fewer cigarettes. Benowitz et al.
reported that among people who reduced from 37 to 5
The distribution of salivary cotinine concentration in relation to the number of cigarettes smoked during the 24 hours prior to  saliva collection Figure 1
The distribution of salivary cotinine concentration in relation to the number of cigarettes smoked during the 
24 hours prior to saliva collection.BMC Public Health 2009, 9:320 http://www.biomedcentral.com/1471-2458/9/320
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The regression lines from linear and quadratic models for men and women Figure 2
The regression lines from linear and quadratic models for men and women.BMC Public Health 2009, 9:320 http://www.biomedcentral.com/1471-2458/9/320
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cigarettes per day on average, the intake of tobacco toxins
per cigarette increased roughly threefold [36]. This could
also explain how cotinine concentrations level-off in
smokers of more than 20 cigarettes per day, when a certain
intake of nicotine is achieved [8,9].
The role of age in cotinine concentrations is still not clear,
since our results, as well as previous studies [7,37], indi-
cated no association between cotinine concentrations and
age, while others have found a significant association
[6,18,29,38]. Some studies have modeled the relation
between cotinine concentrations and cigarette consump-
tion by taking into account several of these variables. The
fit of the multivariate model improved once age, BMI,
educational level, and a quadratic term for cotinine were
included.
Study limitations and strengths
To our knowledge, this is one of the few studies in which
information about tobacco exposure was obtained in a
representative random sample of the general population
with a simultaneous use of a questionnaire and a biologi-
cal marker. In the USA, the National Health and Nutrition
Examination Survey (NHANES) provides population-
based national estimates of smoking prevalence using
both standard questionnaire and serum cotinine concen-
tration [39]. Most previous studies were based on selective
samples from existing observational studies
[6,8,18,25,37] or smoking cessation trials [21,22,29].
Other factors affecting validity also need to be considered.
Although the use of self-reported data from question-
naires could be a source of bias, self-reports on smoking
are accurate and have acceptable validity [40,41]. Coti-
nine is a specific biomarker of tobacco exposure [1,2], and
the laboratory methods are highly sensitive [17].
Some potential limitations deserve consideration. We
found that the model fit could be affected by the measure-
ment scale of the number of cigarettes. Smokers tend to
round up the number of cigarettes smoked, particularly
heavy smokers [42], and hence some information bias
due to digit preference cannot be disregarded. While some
loss of representativeness due to non-response might also
be possible, the sample did not differ by sex, age, and dis-
trict of residence from the Barcelona population. Moreo-
ver, the prevalence of smokers in the sample (28.6% of
men and 18.2% of women) was similar to that derived
from the 2006 Health Interview Survey of Barcelona
(27.3% of men and 20.6% of women) [43]. The participa-
tion rate was almost complete because the study design
allowed replacement of non-respondents by subjects in
the same strata of sex, age, and district of residence.
Conclusion
Cotinine concentration differed by sex and increased up
to consumption of 20 cigarettes per day and then flat-
tened at higher levels of smoking. Further investigation
may help to better understand the relationship between
number of cigarettes smoked, age, sex, weight, subjects'
levels nicotine or cotinine concentrations, and the degree
of nicotine dependence that may have implications in
smoking cessation.
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Table 4: Average increase in cotinine concentration (ng/ml) in adult daily smokers per one cigarette smoked in the previous 24 hours 
by type of regression model.
Estimation of model β * 95% CI R2 p-value†
Men (n = 103)
simple linear model 5.3 3.5, 7.2 0.244 ----
quadratic model 15.7 9.0, 22.3 0.313 < 0.05
quadratic model adjusted for covariates† 14.8 8.1, 21.5 0.353 < 0.05
Women (n = 104)
simple linear model 7.7 5.9, 9.5 0.412 ----
quadratic model 11.2 5.7, 16.7 0.421 0.188
quadratic model adjusted for covariates‡ 11.3 5.8, 16.7 0.458 0.078
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β for the simple variable "number of cigarettes smoked in previous 24 hours" (for one cigarette smoked)
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